FDA's Draft MDUFA VI Commitment Letter: What It Means for AI and Digital Health

◆ ◆ The Wire takeaway

You must prepare for faster FDA review cycles as device timelines shrink and new pre-submission options compress feedback time. Deepening FDA AI expertise means your digital health device submissions will face more technical scrutiny, so adapt your regulatory strategy now to avoid bottlenecks.